Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
29.11
-2.43 (-7.70%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Sensei Biotherapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 11.33 | 13.04 | 18.77 | 19.81 | 15.82 | |
| Research & Development | 10.96 | 18.63 | 18.3 | 30.38 | 21.66 | |
| Operating Expenses | 22.29 | 31.66 | 37.06 | 50.19 | 37.48 | |
| Operating Income | -22.29 | -31.66 | -37.06 | -50.19 | -37.48 | |
| Interest Expense | -0.03 | -0.09 | -0.14 | -0.22 | -0.67 | |
| Interest & Investment Income | 1.24 | 2.55 | 3.62 | 1.78 | 0.8 | |
| Other Non Operating Income (Expenses) | -0.7 | -0.99 | -1.27 | 0.25 | 0.61 | |
| EBT Excluding Unusual Items | -21.78 | -30.19 | -34.86 | -48.37 | -36.75 | |
| Gain (Loss) on Sale of Investments | 0.7 | 0.99 | 1.06 | -0.22 | -0.62 | |
| Gain (Loss) on Sale of Assets | -0 | - | -0.3 | - | - | |
| Asset Writedown | - | -0.95 | - | - | - | |
| Other Unusual Items | - | - | - | - | 0.57 | |
| Pretax Income | -21.09 | -30.16 | -34.1 | -48.59 | -36.79 | |
| Earnings From Continuing Operations | -21.09 | -30.16 | -34.1 | -48.59 | -36.79 | |
| Net Income | -21.09 | -30.16 | -34.1 | -48.59 | -36.79 | |
| Net Income to Common | -21.09 | -30.16 | -34.1 | -48.59 | -36.79 | |
| Shares Outstanding (Basic) | 1 | 1 | 1 | 2 | 1 | |
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 2 | 1 | |
| Shares Change (YoY) | 0.40% | -10.15% | -8.96% | 10.80% | 1618.88% | |
| EPS (Basic) | -16.72 | -24.01 | -24.40 | -31.65 | -26.56 | |
| EPS (Diluted) | -16.72 | -24.01 | -24.40 | -31.65 | -26.56 | |
| Free Cash Flow | -20.47 | -24.82 | -32.2 | -39.35 | -32.29 | |
| Free Cash Flow Per Share | -16.23 | -19.76 | -23.04 | -25.63 | -23.30 | |
| EBITDA | -22.15 | -30.34 | -35.71 | -48.84 | -36.8 | |
| D&A For EBITDA | 0.14 | 1.32 | 1.35 | 1.35 | 0.69 | |
| EBIT | -22.29 | -31.66 | -37.06 | -50.19 | -37.48 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.